Umbria Bioengineering Technologies

Umbria Bioengineering Technologies ("UBT") is an Italian health technology company founded in Assisi in 2015 as an academic spin-off from the University of Perugia's Department of Physics and Geology. It specializes in developing innovative diagnostic medical devices based on proprietary microwave imaging technology that avoids ionizing radiation exposure typical of X-rays. Its lead product "MammoWave" offers non-invasive breast cancer screening without compression or radiation risk—already CE-marked with patents granted across major markets—and has been validated through feasibility studies and multicenter international trials across Europe. Early results for MammoWave show promise for sensitivity (>75%) and specificity (>90%) in breast cancer screening. Additional pipeline products include "BrainWave" for rapid stroke assessment/classification before hospital arrival and "LungWave" targeting lung disease diagnostics—all leveraging similar core microwave-based platforms enhanced by artificial intelligence analytics.